维普中文期刊产品整合服务
75篇 您的检索式:作者名="Goodin DS"
    题名 作者 年代 出处 被引量
1Clinical utility of long latency cognitive event - related potentials( p3 ): the pros显示文摘Goodin DS 1990Electroenceph Clin Neurophysiol1990,76,:1
2The utility of MRI in suspected MS:report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology显示文摘Frohman EM Goodin DS Calabresi PA 0,,:1
3Disease modifying therapies in multiple sclerosis:report of the Therapeutics and Technology Assessment Subcommittee of the American academy of Neurology and the MS Council for Clinical Practice Guidelines显示文摘Goodin DS Frohman EM Garmany GP Jr 0,,:1
4Clinical utility of long latency 'cognitive' event-related potentials (P3): the pros 显示文摘Goodin DS 1990Electroencephalogr Clin Neurophysio1990,76,1:1
5Disease modifying therapies in multiple sclerosis subcomittee of the American Academy of Neurology and MS council for clinical practice guidelines显示文摘Goodin DS Frohama EM Gamany GP 2002Neurology2002,58,2:1
6Long latency event - related com- ponents of the auditory evoked potential in dementia 显示文摘Goodin DS Squires KC Stsrr A 1978Brain1978,101,4:1
7Clinical utility of long latency cognitive event-related potentials (P3):the pros显示文摘 1990EEG Clin Neurophysiol1990,76,:1
8Magnetic resonance imaging in amyotrophic lateral sclerosi显示文摘 Rowley HA olney RK 1988Ann Neurol1988,23,:1
9Relationship between early clinical characteristics and long term disability outcomes:16 year cohort study (follow-up) of the pivotal interferonβ-1b trial in multiple sclerosis显示文摘Goodin DS Traboulsee A Knappertz V 2012J Neurol Neurosurg Psychiatry2012,83,:1
10Disease modifying therapies in multiple sclerosis : report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines 显示文摘Goodin DS Frohman EM Garmany GP 2002Neurology2002,58,2:1
11Long-latency cerebral event-related potentials in multiple sclerosis 显示文摘Aminoff JC Goodin DS 2001J Clin Neurophysiol2001,18,4:1
12Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines 显示文摘Goodin DS Frohman EM Garmany GP 2002Neurology2002,58,2:1
13Disease modifying therapies in multiple sclerosis: subcommittee of the American Academy of Neurology and the MS council for Clinical Practice Guidelines显示文摘Goodin DS Frohama EM Gamany GP 2002Neurology2002,58,2:1
14The use of mitoxantrone(Novantrone)for the treatment of multiple scleFosis: Report of the Th erapeutics and Technology Assessment Subcommittee of the American Academy of Neurology显示文摘Goodin DS Amason BG Coyle PK 2003Neurology2003,61,10:1
15Side effect profile of interferon beta-1b in MS:results of an open label trial显示文摘Newilley LK Goodin DS Goodkin DE 1996Neurology1996,46,2:1
16Long latency cerebral event-related potentials in multip lesclerosis显示文摘Aminoff JC Goodin DS 2001J Clin Neurophysiol2001,18,4:1
17Disease modifying therapies in multiple sclerosis:Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines显示文摘Goodin DS Frohman EM Garmany GP 2002Neurology2002,58,:1
18Disease modifying therapies in multiple sclerosis:report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines显示文摘Goodin DS Frohman EM Garmany GP Jr 2002Neurology2002,58,2:1
19Disease modifying therapies in multiple selerosis:report of the Therapeutics and technology assessment subcommittee of the american academy of neurology and the MS council for clinical practice guidelines显示文摘Goodin DS Frohman EM Garmany GP Jr 2002Neurology2002,58,2:1
20The utility of MRI in suspected MS:Report of the therapeutics and teehnol-ogy Assessment Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurolo gy Society显示文摘Frohman EM Goodin DS Calabresi PA 2003Neurology2003,61,5:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费